#carcinoma — Thursday, July 02, 2026 (1 items)
| 0 | ℹ |
Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.
(nejm.org)
|
New England Journal of Medicine 2026-07-02 | #clinical trial #immunotherapy #carcinoma #adjuvant #hif-inhibitor |